Article

(2022) Curcumin and zinc co-supplementation along with a loss-weight diet can improve lipid profiles in subjects with prediabetes: a multi-arm, parallel-group, randomized, double-blind placebo-controlled phase 2 clinical trial. Diabetology and Metabolic Syndrome.

(2022) Prevalence of cardiovascular diseases and associated factors among adults from southwest Iran: Baseline data from Hoveyzeh Cohort Study. BMC Cardiovascular Disorders.

(2022) Prevalence of prediabetes and associated factors in southwest iran: results from Hoveyzeh cohort study. BMC Endocrine Disorders. p. 72. ISSN 1472-6823 (Electronic) 1472-6823 (Linking)

(2021) Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. eLife.

(2021) The effect of curcumin and zinc co-supplementation on glycemic parameters in overweight or obese prediabetic subjects: A phase 2 randomized, placebo-controlled trial with a multi-arm, parallel-group design. Phytotherapy Research.

(2020) Evaluation of the effect of curcumin and zinc co-supplementation on glycemic measurements, lipid profiles, and inflammatory and antioxidant biomarkers in overweight or obese prediabetic patients: a study protocol for a randomized double-blind placebo-controlled phase 2 clinical trial. Trials. p. 11.

(2020) Repositioning of the global epicentre of non-optimal cholesterol. Nature. pp. 73-77.

(2019) Prevalence of asthma and other allergic conditions in adults in Khuzestan, southwest Iran, 2018. BMC Public Health. p. 13.

(2017) The PERSIAN Cohort: Providing the Evidence Needed for Healthcare Reform. Archives of Iranian Medicine. pp. 691-695. ISSN 1029-2977